Claris Biotherapeutics
Claris Biotherapeutics is a startup headquartered in Jersey City, United States, founded in 2018. It has raised at least $44.5m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Claris Biotherapeutics has raised at least $44.5m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Claris Biotherapeutics sits inside the New York and New Jersey R&D ecosystem in the Global R&D Labs Directory.
Other startups in Jersey City
Related
- Innovation profile of Jersey City
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Claris Biotherapeutics do?
Claris Biotherapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Claris Biotherapeutics raised?
At least $44.5m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Claris Biotherapeutics based?
Claris Biotherapeutics is headquartered in Jersey City, United States.
When was Claris Biotherapeutics founded?
Claris Biotherapeutics was founded in 2018.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.